Functional expression of a DNA-topoisomerase IB from cryptosporidium parvum

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Balaña Fouce, Rafael ^a   Ordóñez, César ^a   Alfonso, Javier ^a   Ordóñez, David ^a  

^a Universidad de Len   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE 1B; POLYPEPTIDE; UNCLASSIFIED DRUG; CAMPTOTHECIN; MUTANT PROTEIN; TOPOTECAN;

ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME STRUCTURE; GENE EXPRESSION SYSTEM; HETEROLOGOUS EXPRESSION; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEADY STATE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS;

CRYPTOSPORIDIUM PARVUM; SACCHAROMYCETALES;

AMINO ACID SEQUENCE; ANIMALS; CAMPTOTHECIN; CRYPTOSPORIDIUM PARVUM; DNA TOPOISOMERASES, TYPE I, EUKARYOTIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; TOPOTECAN;

EID: 68949108016     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/837608     Document Type: Article

References (35)

1. Mosier D. A., Oberst R. D., Cryptosporidiosis: a global challenge Annals of the New York Academy of Sciences 2000 916 102 111
2. Fayer R., Cryptosporidium: a water-borne zoonotic parasite Veterinary Parasitology 2004 126 1-2 37 56
3. Chappell C. L., Okhuysen P. C., Cryptosporidiosis Current Opinion in Infectious Diseases 2002 15 5 523 527
4. Olson M. E., OHandley R. M., Ralston B. J., McAllister T. A., Thompson R. C. A., Update on Cryptosporidium and Giardia infections in cattle Trends in Parasitology 2004 20 4 185 191
5. Mead J. R., Cryptosporidiosis and the challenges of chemotherapy Drug Resistance Updates 2002 5 1 47 57
6. Tzipori S., Widmer G., A hundred-year retrospective on cryptosporidiosis Trends in Parasitology 2008 24 4 184 189
7. Kosek M., Alcantara C., Lima A. A., Guerrant R. L., Cryptosporidiosis: an update Lancet Infectious Diseases 2001 1 4 262 269
8. Tzipori S., Griffiths J., Theodos C., Paromomycin treatment against cryptosporidiosis in patients with AIDS Journal of Infectious Diseases 1995 171 4 1069 1070
9. Tzipori S., Cryptosporidiosis: laboratory investigations and chemotherapy Advances in Parasitology 1998 40 187 221
10. Theodos C. M., Griffiths J. K., DOnfro J., Fairfield A., Tzipori S., Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models Antimicrobial Agents and Chemotherapy 1998 42 8 1959 1965
11. Zardi E. M., Picardi A., Afeltra A., Treatment of cryptosporidiosis in immunocompromised hosts: still an open question Chemotherapy 2005 51 4 193 196
12. Gargala G., Drug treatment and novel drug target against Cryptosporidium Parasite 2008 15 3 275 281
13. Wang J. C., DNA topoisomerases Annual Review of Biochemistry 1996 65 635 692
14. Champoux J. J., DNA topoisomerases: structure, function, and mechanism Annual Review of Biochemistry 2001 70 369 413
15. Corbett K. D., Berger J. M., Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases Annual Review of Biophysics and Biomolecular Structure 2004 33 95 118
16. Mdluli K., Ma Z., Mycobacterium tuberculosis DNA gyrase as a target for drug discovery Infectious Disorders: Drug Targets 2007 7 2 159 168
17. Cheesman S. J., The topoisomerases of protozoan parasites Parasitology Today 2000 16 7 277 281
18. Bakshi R. P., Shapiro T. A., DNA topoisomerases as targets for antiprotozoal therapy Mini Reviews in Medicinal Chemistry 2003 3 6 597 608
19. Balaa-Fouce R., Redondo C. M., Prez-Pertejo Y., Daz-Gonzlez R., Reguera R. M., Targeting atypical trypanosomatid DNA topoisomerase I Drug Discovery Today 2006 11 15-16 733 740
20. Tosh K., Kilbey B., The gene encoding topoisomerase I from the human malaria parasite Plasmodium falciparum Gene 1995 163 1 151 154
21. Tosh K., Cheesman S., Horrocks P., Kilbey B., Plasmodium falciparum: stage-related expression of topoisomerase I Experimental Parasitology 1999 91 2 126 132
22. Christopher L. J., Dykstra C. C., Identification of a type II topoisomerase gene from Cryptosporidium parvum The Journal of Eukaryotic Microbiology 1994 41 5 28S
23. Hann C. L., Carlberg A. L., Bjornsti M.-A., Intragenic suppressors of mutant DNA topoisomerase I-induced lethality diminish enzyme binding of DNA Journal of Biological Chemistry 1998 273 47 31519 31527
24. Abrahamsen M. S., Templeton T. J., Enomoto S., Complete genome sequence of the apicomplexan, Cryptosporidium parvum Science 2004 304 5669 441 445
25. Gietz R. D., Schiestl R. H., Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier Yeast 1991 7 3 253 263
26. Jazwinski S. M., Preparation of extracts from yeast Methods in Enzymology 1990 182 154 174
27. Knab A. M., Fertala J., Bjornsti M.-A., Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants Journal of Biological Chemistry 1993 268 30 22322 22330
28. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Analytical Biochemistry 1976 72 1-2 248 254
29. Stewart L., Ireton G. C., Champoux J. J., The domain organization of human topoisomerase I Journal of Biological Chemistry 1996 271 13 7602 7608
30. Chabot G. G., Clinical pharmacokinetics of irinotecan Clinical Pharmacokinetics 1997 33 4 245 259
31. Rochelle P. A., Upton S. J., Montelone B. A., Woods K., The response of Cryptosporidium parvum to UV light Trends in Parasitology 2005 21 2 81 87
32. Pommier Y., Topoisomerase I inhibitors: camptothecins and beyond Nature Reviews Cancer 2006 6 10 789 802
33. Villa H., Marcos A. R. O., Reguera R. M., A novel active DNA topoisomerase I in Leishmania donovani Journal of Biological Chemistry 2003 278 6 3521 3526
34. Jensen A. D., Svejstrup J. Q., Purification and characterization of human topoisomerase I mutants European Journal of Biochemistry 1996 236 2 389 394
35. Riou J. F., Gabillot M., Philippe M., Schrevel J., Riou G., Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage Biochemistry 1986 25 7 1471 1479